カテゴリー： LP Information, 世界, 医療/バイオ

世界の自己免疫疾患ドラッグデリバリー装置市場予測 2021年-2026年

【英語タイトル】Global Autoimmune Disorder Drug Delivery Devices Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY8736）・商品コード：LPI21MY8736
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：122
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療装置
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「自己免疫疾患ドラッグデリバリー装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ペンインジェクター、自動インジェクター、プレフィルドシリンジ、バイアルなど、用途別には、病院、クリニックなどにセグメント区分してまとめました。自己免疫疾患ドラッグデリバリー装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・自己免疫疾患ドラッグデリバリー装置の世界市場概要（サマリー）
・自己免疫疾患ドラッグデリバリー装置の企業別販売量・売上
・自己免疫疾患ドラッグデリバリー装置の企業別市場シェア
・自己免疫疾患ドラッグデリバリー装置の世界市場規模 2016年-2021年：種類別（ペンインジェクター、自動インジェクター、プレフィルドシリンジ、バイアル）
・自己免疫疾患ドラッグデリバリー装置の世界市場規模 2016年-2021年：用途別（病院、クリニック）
・自己免疫疾患ドラッグデリバリー装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・自己免疫疾患ドラッグデリバリー装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・自己免疫疾患ドラッグデリバリー装置のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・自己免疫疾患ドラッグデリバリー装置の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・自己免疫疾患ドラッグデリバリー装置市場の成長要因・課題・動向
・自己免疫疾患ドラッグデリバリー装置の世界市場予測 2021年-2026年
・自己免疫疾患ドラッグデリバリー装置の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・自己免疫疾患ドラッグデリバリー装置のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・自己免疫疾患ドラッグデリバリー装置のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・自己免疫疾患ドラッグデリバリー装置の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・自己免疫疾患ドラッグデリバリー装置の世界市場予測：種類別（ペンインジェクター、自動インジェクター、プレフィルドシリンジ、バイアル）
・自己免疫疾患ドラッグデリバリー装置の世界市場予測：用途別（病院、クリニック）
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Autoimmune Disorder Drug Delivery Devices will have significant change from previous year. By the most conservative estimates of global Autoimmune Disorder Drug Delivery Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Autoimmune Disorder Drug Delivery Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Autoimmune Disorder Drug Delivery Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Pen Injectors
Auto-Injectors
Pre-filled Syringes
Vials

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Clinic

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
BD
Gerresheimer
Schott
J.O.Pharma
Nipro
Roselabs
Fresenius Kabi
Baxter
West Pharma
Terumo
Taisei Kako
MedXL
Cardinal Health
Guerbet
Catalent
Weigao
Stevanato
Rovi CM
Zibo Minkang
Vetter Pharma

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Autoimmune Disorder Drug Delivery Devices Consumption 2016-2026
2.1.2 Autoimmune Disorder Drug Delivery Devices Consumption CAGR by Region
2.2 Autoimmune Disorder Drug Delivery Devices Segment by Type
2.2.1 Pen Injectors
2.2.2 Auto-Injectors
2.2.3 Pre-filled Syringes
2.2.4 Vials
2.3 Autoimmune Disorder Drug Delivery Devices Sales by Type
2.3.1 Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2016-2021)
2.3.2 Global Autoimmune Disorder Drug Delivery Devices Revenue and Market Share by Type (2016-2021)
2.3.3 Global Autoimmune Disorder Drug Delivery Devices Sale Price by Type (2016-2021)
2.4 Autoimmune Disorder Drug Delivery Devices Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Autoimmune Disorder Drug Delivery Devices Sales by Application
2.5.1 Global Autoimmune Disorder Drug Delivery Devices Sale Market Share by Application (2016-2021)
2.5.2 Global Autoimmune Disorder Drug Delivery Devices Revenue and Market Share by Application (2016-2021)
2.5.3 Global Autoimmune Disorder Drug Delivery Devices Sale Price by Application (2016-2021)

3 Global Autoimmune Disorder Drug Delivery Devices by Company
3.1 Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Company
3.1.1 Global Autoimmune Disorder Drug Delivery Devices Sales by Company (2019-2021)
3.1.2 Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Company (2019-2021)
3.2 Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Company
3.2.1 Global Autoimmune Disorder Drug Delivery Devices Revenue by Company (2019-2021)
3.2.2 Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Company (2019-2021)
3.3 Global Autoimmune Disorder Drug Delivery Devices Sale Price by Company
3.4 Global Manufacturers Autoimmune Disorder Drug Delivery Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Autoimmune Disorder Drug Delivery Devices Product Location Distribution
3.4.2 Players Autoimmune Disorder Drug Delivery Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Autoimmune Disorder Drug Delivery Devices by Region
4.1 Global Autoimmune Disorder Drug Delivery Devices by Region
4.1.1 Global Autoimmune Disorder Drug Delivery Devices Sales by Region
4.1.2 Global Autoimmune Disorder Drug Delivery Devices Revenue by Region
4.2 Americas Autoimmune Disorder Drug Delivery Devices Sales Growth
4.3 APAC Autoimmune Disorder Drug Delivery Devices Sales Growth
4.4 Europe Autoimmune Disorder Drug Delivery Devices Sales Growth
4.5 Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales Growth

5 Americas
5.1 Americas Autoimmune Disorder Drug Delivery Devices Sales by Country
5.1.1 Americas Autoimmune Disorder Drug Delivery Devices Sales by Country (2016-2021)
5.1.2 Americas Autoimmune Disorder Drug Delivery Devices Revenue by Country (2016-2021)
5.2 Americas Autoimmune Disorder Drug Delivery Devices Sales by Type
5.3 Americas Autoimmune Disorder Drug Delivery Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Autoimmune Disorder Drug Delivery Devices Sales by Region
6.1.1 APAC Autoimmune Disorder Drug Delivery Devices Sales by Region (2016-2021)
6.1.2 APAC Autoimmune Disorder Drug Delivery Devices Revenue by Region (2016-2021)
6.2 APAC Autoimmune Disorder Drug Delivery Devices Sales by Type
6.3 APAC Autoimmune Disorder Drug Delivery Devices Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Autoimmune Disorder Drug Delivery Devices by Country
7.1.1 Europe Autoimmune Disorder Drug Delivery Devices Sales by Country (2016-2021)
7.1.2 Europe Autoimmune Disorder Drug Delivery Devices Revenue by Country (2016-2021)
7.2 Europe Autoimmune Disorder Drug Delivery Devices Sales by Type
7.3 Europe Autoimmune Disorder Drug Delivery Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Autoimmune Disorder Drug Delivery Devices by Country
8.1.1 Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales by Country (2016-2021)
8.1.2 Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue by Country (2016-2021)
8.2 Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales by Type
8.3 Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Autoimmune Disorder Drug Delivery Devices Distributors
10.3 Autoimmune Disorder Drug Delivery Devices Customer

11 Global Autoimmune Disorder Drug Delivery Devices Market Forecast
11.1 Global Autoimmune Disorder Drug Delivery Devices Forecast by Region
11.1.1 Global Autoimmune Disorder Drug Delivery Devices Forecast by Regions (2021-2026)
11.2.2 Global Autoimmune Disorder Drug Delivery Devices Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Autoimmune Disorder Drug Delivery Devices Forecast by Type
11.7 Global Autoimmune Disorder Drug Delivery Devices Forecast by Application

12 Key Players Analysis
12.1 BD
12.1.1 BD Company Information
12.1.2 BD Autoimmune Disorder Drug Delivery Devices Product Offered
12.1.3 BD Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 BD Main Business Overview
12.1.5 BD Latest Developments
12.2 Gerresheimer
12.2.1 Gerresheimer Company Information
12.2.2 Gerresheimer Autoimmune Disorder Drug Delivery Devices Product Offered
12.2.3 Gerresheimer Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Gerresheimer Main Business Overview
12.2.5 Gerresheimer Latest Developments
12.3 Schott
12.3.1 Schott Company Information
12.3.2 Schott Autoimmune Disorder Drug Delivery Devices Product Offered
12.3.3 Schott Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Schott Main Business Overview
12.3.5 Schott Latest Developments
12.4 J.O.Pharma
12.4.1 J.O.Pharma Company Information
12.4.2 J.O.Pharma Autoimmune Disorder Drug Delivery Devices Product Offered
12.4.3 J.O.Pharma Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 J.O.Pharma Main Business Overview
12.4.5 J.O.Pharma Latest Developments
12.5 Nipro
12.5.1 Nipro Company Information
12.5.2 Nipro Autoimmune Disorder Drug Delivery Devices Product Offered
12.5.3 Nipro Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Nipro Main Business Overview
12.5.5 Nipro Latest Developments
12.6 Roselabs
12.6.1 Roselabs Company Information
12.6.2 Roselabs Autoimmune Disorder Drug Delivery Devices Product Offered
12.6.3 Roselabs Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Roselabs Main Business Overview
12.6.5 Roselabs Latest Developments
12.7 Fresenius Kabi
12.7.1 Fresenius Kabi Company Information
12.7.2 Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Product Offered
12.7.3 Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Fresenius Kabi Main Business Overview
12.7.5 Fresenius Kabi Latest Developments
12.8 Baxter
12.8.1 Baxter Company Information
12.8.2 Baxter Autoimmune Disorder Drug Delivery Devices Product Offered
12.8.3 Baxter Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Baxter Main Business Overview
12.8.5 Baxter Latest Developments
12.9 West Pharma
12.9.1 West Pharma Company Information
12.9.2 West Pharma Autoimmune Disorder Drug Delivery Devices Product Offered
12.9.3 West Pharma Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 West Pharma Main Business Overview
12.9.5 West Pharma Latest Developments
12.10 Terumo
12.10.1 Terumo Company Information
12.10.2 Terumo Autoimmune Disorder Drug Delivery Devices Product Offered
12.10.3 Terumo Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Terumo Main Business Overview
12.10.5 Terumo Latest Developments
12.11 Taisei Kako
12.11.1 Taisei Kako Company Information
12.11.2 Taisei Kako Autoimmune Disorder Drug Delivery Devices Product Offered
12.11.3 Taisei Kako Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Taisei Kako Main Business Overview
12.11.5 Taisei Kako Latest Developments
12.12 MedXL
12.12.1 MedXL Company Information
12.12.2 MedXL Autoimmune Disorder Drug Delivery Devices Product Offered
12.12.3 MedXL Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 MedXL Main Business Overview
12.12.5 MedXL Latest Developments
12.13 Cardinal Health
12.13.1 Cardinal Health Company Information
12.13.2 Cardinal Health Autoimmune Disorder Drug Delivery Devices Product Offered
12.13.3 Cardinal Health Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Cardinal Health Main Business Overview
12.13.5 Cardinal Health Latest Developments
12.14 Guerbet
12.14.1 Guerbet Company Information
12.14.2 Guerbet Autoimmune Disorder Drug Delivery Devices Product Offered
12.14.3 Guerbet Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Guerbet Main Business Overview
12.14.5 Guerbet Latest Developments
12.15 Catalent
12.15.1 Catalent Company Information
12.15.2 Catalent Autoimmune Disorder Drug Delivery Devices Product Offered
12.15.3 Catalent Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Catalent Main Business Overview
12.15.5 Catalent Latest Developments
12.16 Weigao
12.16.1 Weigao Company Information
12.16.2 Weigao Autoimmune Disorder Drug Delivery Devices Product Offered
12.16.3 Weigao Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Weigao Main Business Overview
12.16.5 Weigao Latest Developments
12.17 Stevanato
12.17.1 Stevanato Company Information
12.17.2 Stevanato Autoimmune Disorder Drug Delivery Devices Product Offered
12.17.3 Stevanato Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Stevanato Main Business Overview
12.17.5 Stevanato Latest Developments
12.18 Rovi CM
12.18.1 Rovi CM Company Information
12.18.2 Rovi CM Autoimmune Disorder Drug Delivery Devices Product Offered
12.18.3 Rovi CM Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Rovi CM Main Business Overview
12.18.5 Rovi CM Latest Developments
12.19 Zibo Minkang
12.19.1 Zibo Minkang Company Information
12.19.2 Zibo Minkang Autoimmune Disorder Drug Delivery Devices Product Offered
12.19.3 Zibo Minkang Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 Zibo Minkang Main Business Overview
12.19.5 Zibo Minkang Latest Developments
12.20 Vetter Pharma
12.20.1 Vetter Pharma Company Information
12.20.2 Vetter Pharma Autoimmune Disorder Drug Delivery Devices Product Offered
12.20.3 Vetter Pharma Autoimmune Disorder Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Vetter Pharma Main Business Overview
12.20.5 Vetter Pharma Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Autoimmune Disorder Drug Delivery Devices Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Pen Injectors
Table 3. Major Players of Auto-Injectors
Table 4. Major Players of Pre-filled Syringes
Table 5. Major Players of Vials
Table 6. Global Autoimmune Disorder Drug Delivery Devices Sales by Type (2016-2021) & (K Units)
Table 7. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2016-2021)
Table 8. Global Autoimmune Disorder Drug Delivery Devices Revenue by Type (2016-2021) & ($ million)
Table 9. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Type (2016-2021)
Table 10. Global Autoimmune Disorder Drug Delivery Devices Sale Price by Type (2016-2021)
Table 11. Global Autoimmune Disorder Drug Delivery Devices Sales by Application (2016-2021) & (K Units)
Table 12. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2016-2021)
Table 13. Global Autoimmune Disorder Drug Delivery Devices Value by Application (2016-2021)
Table 14. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Application (2016-2021)
Table 15. Global Autoimmune Disorder Drug Delivery Devices Sale Price by Application (2016-2021)
Table 16. Global Autoimmune Disorder Drug Delivery Devices Sales by Company (2019-2021) & (K Units)
Table 17. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Company (2019-2021)
Table 18. Global Autoimmune Disorder Drug Delivery Devices Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Company (2019-2021)
Table 20. Global Autoimmune Disorder Drug Delivery Devices Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Autoimmune Disorder Drug Delivery Devices Producing Area Distribution and Sales Area
Table 22. Players Autoimmune Disorder Drug Delivery Devices Products Offered
Table 23. Autoimmune Disorder Drug Delivery Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Autoimmune Disorder Drug Delivery Devices Sales by Region (2016-2021) (K Units)
Table 27. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Region (2016-2021)
Table 28. Global Autoimmune Disorder Drug Delivery Devices Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Region (2016-2021)
Table 30. Americas Autoimmune Disorder Drug Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 31. Americas Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country (2016-2021)
Table 32. Americas Autoimmune Disorder Drug Delivery Devices Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country (2016-2021)
Table 34. Americas Autoimmune Disorder Drug Delivery Devices Sales by Type (2016-2021) & (K Units)
Table 35. Americas Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2016-2021)
Table 36. Americas Autoimmune Disorder Drug Delivery Devices Sales by Application (2016-2021) & (K Units)
Table 37. Americas Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2016-2021)
Table 38. APAC Autoimmune Disorder Drug Delivery Devices Sales by Region (2016-2021) & (K Units)
Table 39. APAC Autoimmune Disorder Drug Delivery Devices Sales Market Share by Region (2016-2021)
Table 40. APAC Autoimmune Disorder Drug Delivery Devices Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Region (2016-2021)
Table 42. APAC Autoimmune Disorder Drug Delivery Devices Sales by Type (2016-2021) & (K Units)
Table 43. APAC Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2016-2021)
Table 44. APAC Autoimmune Disorder Drug Delivery Devices Sales by Application (2016-2021) & (K Units)
Table 45. APAC Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2016-2021)
Table 46. Europe Autoimmune Disorder Drug Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 47. Europe Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country (2016-2021)
Table 48. Europe Autoimmune Disorder Drug Delivery Devices Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country (2016-2021)
Table 50. Europe Autoimmune Disorder Drug Delivery Devices Sales by Type (2016-2021) & (K Units)
Table 51. Europe Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2016-2021)
Table 52. Europe Autoimmune Disorder Drug Delivery Devices Sales by Application (2016-2021) & (K Units)
Table 53. Europe Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 55. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales by Type (2016-2021) & (K Units)
Table 59. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales by Application (2016-2021) & (K Units)
Table 61. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Autoimmune Disorder Drug Delivery Devices
Table 63. Key Application and Potential Industries of Autoimmune Disorder Drug Delivery Devices
Table 64. Key Challenges of Autoimmune Disorder Drug Delivery Devices
Table 65. Key Trends of Autoimmune Disorder Drug Delivery Devices
Table 66. Autoimmune Disorder Drug Delivery Devices Distributors List
Table 67. Autoimmune Disorder Drug Delivery Devices Customer List
Table 68. Global Autoimmune Disorder Drug Delivery Devices Sales Forecast by Region (2021-2026) & (K Units)
Table 69. Global Autoimmune Disorder Drug Delivery Devices Consumption Market Forecast by Region
Table 70. Global Autoimmune Disorder Drug Delivery Devices Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Autoimmune Disorder Drug Delivery Devices Sales Forecast by Country (2021-2026) & (K Units)
Table 73. Americas Autoimmune Disorder Drug Delivery Devices Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Autoimmune Disorder Drug Delivery Devices Sales Forecast by Region (2021-2026) & (K Units)
Table 75. APAC Autoimmune Disorder Drug Delivery Devices Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Autoimmune Disorder Drug Delivery Devices Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Europe Autoimmune Disorder Drug Delivery Devices Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Autoimmune Disorder Drug Delivery Devices Sales Forecast by Type (2021-2026) & (K Units)
Table 81. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Autoimmune Disorder Drug Delivery Devices Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Autoimmune Disorder Drug Delivery Devices Sales Forecast by Application (2021-2026) & (K Units)
Table 85. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Autoimmune Disorder Drug Delivery Devices Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share Forecast by Application (2021-2026)
Table 88. BD Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 89. BD Autoimmune Disorder Drug Delivery Devices Product Offered
Table 90. BD Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 91. BD Main Business
Table 92. BD Latest Developments
Table 93. Gerresheimer Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 94. Gerresheimer Autoimmune Disorder Drug Delivery Devices Product Offered
Table 95. Gerresheimer Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 96. Gerresheimer Main Business
Table 97. Gerresheimer Latest Developments
Table 98. Schott Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 99. Schott Autoimmune Disorder Drug Delivery Devices Product Offered
Table 100. Schott Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 101. Schott Main Business
Table 102. Schott Latest Developments
Table 103. J.O.Pharma Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 104. J.O.Pharma Autoimmune Disorder Drug Delivery Devices Product Offered
Table 105. J.O.Pharma Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 106. J.O.Pharma Main Business
Table 107. J.O.Pharma Latest Developments
Table 108. Nipro Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 109. Nipro Autoimmune Disorder Drug Delivery Devices Product Offered
Table 110. Nipro Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 111. Nipro Main Business
Table 112. Nipro Latest Developments
Table 113. Roselabs Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 114. Roselabs Autoimmune Disorder Drug Delivery Devices Product Offered
Table 115. Roselabs Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 116. Roselabs Main Business
Table 117. Roselabs Latest Developments
Table 118. Fresenius Kabi Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 119. Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Product Offered
Table 120. Fresenius Kabi Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 121. Fresenius Kabi Main Business
Table 122. Fresenius Kabi Latest Developments
Table 123. Baxter Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 124. Baxter Autoimmune Disorder Drug Delivery Devices Product Offered
Table 125. Baxter Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 126. Baxter Main Business
Table 127. Baxter Latest Developments
Table 128. West Pharma Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 129. West Pharma Autoimmune Disorder Drug Delivery Devices Product Offered
Table 130. West Pharma Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 131. West Pharma Main Business
Table 132. West Pharma Latest Developments
Table 133. Terumo Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 134. Terumo Autoimmune Disorder Drug Delivery Devices Product Offered
Table 135. Terumo Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 136. Terumo Main Business
Table 137. Terumo Latest Developments
Table 138. Taisei Kako Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 139. Taisei Kako Autoimmune Disorder Drug Delivery Devices Product Offered
Table 140. Taisei Kako Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 141. Taisei Kako Main Business
Table 142. Taisei Kako Latest Developments
Table 143. MedXL Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 144. MedXL Autoimmune Disorder Drug Delivery Devices Product Offered
Table 145. MedXL Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 146. MedXL Main Business
Table 147. MedXL Latest Developments
Table 148. Cardinal Health Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 149. Cardinal Health Autoimmune Disorder Drug Delivery Devices Product Offered
Table 150. Cardinal Health Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 151. Cardinal Health Main Business
Table 152. Cardinal Health Latest Developments
Table 153. Guerbet Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 154. Guerbet Autoimmune Disorder Drug Delivery Devices Product Offered
Table 155. Guerbet Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 156. Guerbet Main Business
Table 157. Guerbet Latest Developments
Table 158. Catalent Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 159. Catalent Autoimmune Disorder Drug Delivery Devices Product Offered
Table 160. Catalent Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 161. Catalent Main Business
Table 162. Catalent Latest Developments
Table 163. Weigao Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 164. Weigao Autoimmune Disorder Drug Delivery Devices Product Offered
Table 165. Weigao Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 166. Weigao Main Business
Table 167. Weigao Latest Developments
Table 168. Stevanato Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 169. Stevanato Autoimmune Disorder Drug Delivery Devices Product Offered
Table 170. Stevanato Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 171. Stevanato Main Business
Table 172. Stevanato Latest Developments
Table 173. Rovi CM Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 174. Rovi CM Autoimmune Disorder Drug Delivery Devices Product Offered
Table 175. Rovi CM Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 176. Rovi CM Main Business
Table 177. Rovi CM Latest Developments
Table 178. Zibo Minkang Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 179. Zibo Minkang Autoimmune Disorder Drug Delivery Devices Product Offered
Table 180. Zibo Minkang Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 181. Zibo Minkang Main Business
Table 182. Zibo Minkang Latest Developments
Table 183. Vetter Pharma Basic Information, Autoimmune Disorder Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 184. Vetter Pharma Autoimmune Disorder Drug Delivery Devices Product Offered
Table 185. Vetter Pharma Autoimmune Disorder Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 186. Vetter Pharma Main Business
Table 187. Vetter Pharma Latest Developments
List of Figures
Figure 1. Picture of Autoimmune Disorder Drug Delivery Devices
Figure 2. Autoimmune Disorder Drug Delivery Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Autoimmune Disorder Drug Delivery Devices Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Autoimmune Disorder Drug Delivery Devices Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Autoimmune Disorder Drug Delivery Devices Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Pen Injectors
Figure 10. Product Picture of Auto-Injectors
Figure 11. Product Picture of Pre-filled Syringes
Figure 12. Product Picture of Vials
Figure 13. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type in 2020
Figure 14. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Type (2016-2021)
Figure 15. Autoimmune Disorder Drug Delivery Devices Consumed in Hospital
Figure 16. Global Autoimmune Disorder Drug Delivery Devices Market: Hospital (2016-2021) & (K Units)
Figure 17. Autoimmune Disorder Drug Delivery Devices Consumed in Clinic
Figure 18. Global Autoimmune Disorder Drug Delivery Devices Market: Clinic (2016-2021) & (K Units)
Figure 19. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application (2016-2021)
Figure 20. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Application in 2020
Figure 21. Autoimmune Disorder Drug Delivery Devices Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Company in 2020
Figure 23. Global Autoimmune Disorder Drug Delivery Devices Sales Market Share by Regions (2016-2021)
Figure 24. Global Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Region in 2020
Figure 25. Americas Autoimmune Disorder Drug Delivery Devices Sales 2016-2021 (K Units)
Figure 26. Americas Autoimmune Disorder Drug Delivery Devices Revenue 2016-2021 ($ Millions)
Figure 27. APAC Autoimmune Disorder Drug Delivery Devices Sales 2016-2021 (K Units)
Figure 28. APAC Autoimmune Disorder Drug Delivery Devices Revenue 2016-2021 ($ Millions)
Figure 29. Europe Autoimmune Disorder Drug Delivery Devices Sales 2016-2021 (K Units)
Figure 30. Europe Autoimmune Disorder Drug Delivery Devices Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue 2016-2021 ($ Millions)
Figure 33. Americas Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country in 2020
Figure 34. Americas Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country in 2020
Figure 35. Americas Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type in 2020
Figure 36. Americas Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application in 2020
Figure 37. United States Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Autoimmune Disorder Drug Delivery Devices Sales Market Share by Region in 2020
Figure 42. APAC Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Regions in 2020
Figure 43. APAC Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type in 2020
Figure 44. APAC Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application in 2020
Figure 45. China Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country in 2020
Figure 52. Europe Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country in 2020
Figure 53. Europe Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type in 2020
Figure 54. Europe Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application in 2020
Figure 55. Germany Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Autoimmune Disorder Drug Delivery Devices Sales Market Share by Application in 2020
Figure 64. Egypt Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Autoimmune Disorder Drug Delivery Devices Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles


★調査レポート[世界の自己免疫疾患ドラッグデリバリー装置市場予測 2021年-2026年] (コード：LPI21MY8736)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の自己免疫疾患ドラッグデリバリー装置市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の経鼻ドラッグデリバリーデバイス市場予測 2021年-2026年
    LPI21MY9135 / LP Information / 2021年5月 / LPインフォメーション社の「経鼻ドラッグデリバリーデバイスの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、マルチドーズ、ユニ/ビドースなど、用途別には、個人用、病院用などにセグメント区分してまとめました。経鼻ドラッグデリバリーデバイスのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・経鼻ドラッグデリバリーデバイスの世界市場概要（サマリー） ・経鼻ドラッグデリバリーデバイスの企業別販売量・売上 ・経鼻ドラッグデリバリーデバイスの企業別市場シェア ・経鼻ドラッグデリバリーデバイスの世界市場規模 2016年-2021年：種類別（マルチドーズ、ユニ/ビドース） ・経鼻ドラッグデリバリーデバイスの世界市場規模 2016年-2021年：用途別（個人用、病院用） ・経鼻ドラッグデリバリーデバイスの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・経鼻ドラッグデリバリーデバイスのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Nasal Drug Delivery Devices will have significant change from previous year. By the most conservative estimates of global Nasal Drug Delivery Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Nasal Drug Delivery Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Nasal Drug Delivery Devices...
  • 世界の注射型ドラッグデリバリーシステム市場予測 2021年-2026年
    LPI21MY9247 / LP Information / 2021年5月 / LPインフォメーション社の「注射型ドラッグデリバリーシステムの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、従来型装置、自己注入装置、その他など、用途別には、病院、クリニック、個人、その他などにセグメント区分してまとめました。注射型ドラッグデリバリーシステムのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・注射型ドラッグデリバリーシステムの世界市場概要（サマリー） ・注射型ドラッグデリバリーシステムの企業別販売量・売上 ・注射型ドラッグデリバリーシステムの企業別市場シェア ・注射型ドラッグデリバリーシステムの世界市場規模 2016年-2021年：種類別（従来型装置、自己注入装置、その他） ・注射型ドラッグデリバリーシステムの世界市場規模 2016年-2021年：用途別（病院、クリニック、個人、その他） ・注射型ドラッグデリバリーシステムの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・注射型ドラッグデリバリーシステムのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Injectable Drug Delivery System will have significant change from previous year. By the most conservative estimates of global Injectable Drug Delivery System market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Injectable Drug Delivery System market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Drug Delivery System...
  • 世界の単位用量ドラッグデリバリーシステム市場予測 2021年-2026年
    LPI21MY9315 / LP Information / 2021年5月 / LPインフォメーション社の「単位用量ドラッグデリバリーシステムの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ブリスターパック、プレフィラブルシリンジ、アンプル、その他など、用途別には、経口薬、注射薬、その他などにセグメント区分してまとめました。単位用量ドラッグデリバリーシステムのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・単位用量ドラッグデリバリーシステムの世界市場概要（サマリー） ・単位用量ドラッグデリバリーシステムの企業別販売量・売上 ・単位用量ドラッグデリバリーシステムの企業別市場シェア ・単位用量ドラッグデリバリーシステムの世界市場規模 2016年-2021年：種類別（ブリスターパック、プレフィラブルシリンジ、アンプル、その他） ・単位用量ドラッグデリバリーシステムの世界市場規模 2016年-2021年：用途別（経口薬、注射薬、その他） ・単位用量ドラッグデリバリーシステムの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・単位用量ドラッグデリバリーシステムのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Unit Dose Drug Delivery Systems will have significant change from previous year. By the most conservative estimates of global Unit Dose Drug Delivery Systems market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Unit Dose Drug Delivery Systems market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Unit...
  • 世界のニードルフリードラッグデリバリーシステム市場予測 2021年-2026年
    LPI21MY9140 / LP Information / 2021年5月 / LPインフォメーション社の「ニードルフリードラッグデリバリーシステムの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ジェットベース、スプリングベース、レーザーベースなど、用途別には、病院、クリニック、その他などにセグメント区分してまとめました。ニードルフリードラッグデリバリーシステムのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ニードルフリードラッグデリバリーシステムの世界市場概要（サマリー） ・ニードルフリードラッグデリバリーシステムの企業別販売量・売上 ・ニードルフリードラッグデリバリーシステムの企業別市場シェア ・ニードルフリードラッグデリバリーシステムの世界市場規模 2016年-2021年：種類別（ジェットベース、スプリングベース、レーザーベース） ・ニードルフリードラッグデリバリーシステムの世界市場規模 2016年-2021年：用途別（病院、クリニック、その他） ・ニードルフリードラッグデリバリーシステムの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ニードルフリードラッグデリバリーシステムのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Needle-Free Drug Delivery Systems will have significant change from previous year. By the most conservative estimates of global Needle-Free Drug Delivery Systems market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Needle-Free Drug Delivery Systems market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Needle-Free Drug Delivery Systems...
  • 世界の双極性障害治療薬市場予測 2021年-2026年
    LPI21MY9449 / LP Information / 2021年5月 / LPインフォメーション社の「双極性障害治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、気分安定薬、抗精神病薬、抗うつ薬、その他薬品など、用途別には、病院、研究室、その他などにセグメント区分してまとめました。双極性障害治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・双極性障害治療薬の世界市場概要（サマリー） ・双極性障害治療薬の企業別販売量・売上 ・双極性障害治療薬の企業別市場シェア ・双極性障害治療薬の世界市場規模 2016年-2021年：種類別（気分安定薬、抗精神病薬、抗うつ薬、その他薬品） ・双極性障害治療薬の世界市場規模 2016年-2021年：用途別（病院、研究室、その他） ・双極性障害治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・双極性障害治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Bipolar Disorder Drugs will have significant change from previous year. By the most conservative estimates of global Bipolar Disorder Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Bipolar Disorder Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Bipolar Disorder Drugs market by product type,...
  • 世界のヒトインスリンデリバリーシステム市場予測 2021年-2026年
    LPI21MY9231 / LP Information / 2021年5月 / LPインフォメーション社の「ヒトインスリンデリバリーシステムの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、自動、手動など、用途別には、病院、クリニック、ホームケアなどにセグメント区分してまとめました。ヒトインスリンデリバリーシステムのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ヒトインスリンデリバリーシステムの世界市場概要（サマリー） ・ヒトインスリンデリバリーシステムの企業別販売量・売上 ・ヒトインスリンデリバリーシステムの企業別市場シェア ・ヒトインスリンデリバリーシステムの世界市場規模 2016年-2021年：種類別（自動、手動） ・ヒトインスリンデリバリーシステムの世界市場規模 2016年-2021年：用途別（病院、クリニック、ホームケア） ・ヒトインスリンデリバリーシステムの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ヒトインスリンデリバリーシステムのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Human Insulin Delivery System will have significant change from previous year. By the most conservative estimates of global Human Insulin Delivery System market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Human Insulin Delivery System market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Human Insulin Delivery System...
  • 世界の薬物スクリーニング市場予測 2021年-2026年
    LPI21MY8945 / LP Information / 2021年5月 / LPインフォメーション社の「薬物スクリーニングの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、イムノアッセイ分析計、クロマトグラフィー、ブレス分析計、迅速検査装置、アッセイキット・試薬など、用途別には、病院、研究所、バイオテクノロジー・製薬会社、その他などにセグメント区分してまとめました。薬物スクリーニングのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・薬物スクリーニングの世界市場概要（サマリー） ・薬物スクリーニングの企業別販売量・売上 ・薬物スクリーニングの企業別市場シェア ・薬物スクリーニングの世界市場規模 2016年-2021年：種類別（イムノアッセイ分析計、クロマトグラフィー、ブレス分析計、迅速検査装置、アッセイキット・試薬） ・薬物スクリーニングの世界市場規模 2016年-2021年：用途別（病院、研究所、バイオテクノロジー・製薬会社、その他） ・薬物スクリーニングの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・薬物スクリーニングのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Drug Screening will have significant change from previous year. By the most conservative estimates of global Drug Screening market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 4000.9 million in 2019. Over the next five years the Drug Screening market will register a 5.8% CAGR in terms of revenue, the global market size will reach US$ 5006.2 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Drug Screening market by product type, application, key manufacturers and...
  • 世界のバルクデリバリーシステム市場予測 2021年-2026年
    LPI21MY0877 / LP Information / 2021年5月 / LPインフォメーション社の「バルクデリバリーシステムの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、5ガロンバルクアンローダー、55ガロンバルクアンローダー、その他など、用途別には、食品産業、農業、その他などにセグメント区分してまとめました。バルクデリバリーシステムのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・バルクデリバリーシステムの世界市場概要（サマリー） ・バルクデリバリーシステムの企業別販売量・売上 ・バルクデリバリーシステムの企業別市場シェア ・バルクデリバリーシステムの世界市場規模 2016年-2021年：種類別（5ガロンバルクアンローダー、55ガロンバルクアンローダー、その他） ・バルクデリバリーシステムの世界市場規模 2016年-2021年：用途別（食品産業、農業、その他） ・バルクデリバリーシステムの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・バルクデリバリーシステムのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Bulk Delivery System will have significant change from previous year. By the most conservative estimates of global Bulk Delivery System market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Bulk Delivery System market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Bulk Delivery System market by product type,...
  • 世界のゴセレリン薬市場予測 2021年-2026年
    LPI21MY9545 / LP Information / 2021年5月 / LPインフォメーション社の「ゴセレリン薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、3.6mg、10.8mgなど、用途別には、前立腺がん、乳がん、子宮内膜症、その他などにセグメント区分してまとめました。ゴセレリン薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ゴセレリン薬の世界市場概要（サマリー） ・ゴセレリン薬の企業別販売量・売上 ・ゴセレリン薬の企業別市場シェア ・ゴセレリン薬の世界市場規模 2016年-2021年：種類別（3.6mg、10.8mg） ・ゴセレリン薬の世界市場規模 2016年-2021年：用途別（前立腺がん、乳がん、子宮内膜症、その他） ・ゴセレリン薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ゴセレリン薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Goserelin Drug will have significant change from previous year. By the most conservative estimates of global Goserelin Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Goserelin Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Goserelin Drug market by product type, application, key manufacturers and...
  • 世界の分娩後出血治療薬市場予測 2021年-2026年
    LPI21MY9628 / LP Information / 2021年5月 / LPインフォメーション社の「分娩後出血治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、経口、注射など、用途別には、病院、診療所、その他などにセグメント区分してまとめました。分娩後出血治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・分娩後出血治療薬の世界市場概要（サマリー） ・分娩後出血治療薬の企業別販売量・売上 ・分娩後出血治療薬の企業別市場シェア ・分娩後出血治療薬の世界市場規模 2016年-2021年：種類別（経口、注射） ・分娩後出血治療薬の世界市場規模 2016年-2021年：用途別（病院、診療所、その他） ・分娩後出血治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・分娩後出血治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Postpartum Bleeding Drug will have significant change from previous year. By the most conservative estimates of global Postpartum Bleeding Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Postpartum Bleeding Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Postpartum Bleeding Drug market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆